GMED - Globus Medical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GMED is currently covered by 14 analysts with an average price target of $71.45. This is a potential upside of $12.27 (20.73%) from yesterday's end of day stock price of $59.18.

Globus Medical's activity chart (see below) currently has 213 price targets and 217 ratings on display. The stock rating distribution of GMED is 42.86% HOLD, 54.29% BUY and 2.86% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.98% with an average time for these price targets to be met of 294.7 days.

Highest price target for GMED is $115, Lowest price target is $68, average price target is $93.88.

Most recent stock forecast was given by RYAN ZIMMERMAN from BTIG on 27-May-2025. First documented stock forecast 17-Jun-2013.

Currently out of the existing stock ratings of GMED, 30 are a HOLD (42.86%), 38 are a BUY (54.29%), 2 are a SELL (2.86%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$91

4 days ago
(27-May-2025)

15/15 (100%)

$8.29 (10.02%)

133

Hold

4 days ago
(27-May-2025)

1/1 (100%)

$4.73 (18.01%)

469

Hold

$68

$8.82 (14.90%)

$80

19 days ago
(12-May-2025)

24/28 (85.71%)

$8.99 (15.23%)

347

Buy

$80

$20.82 (35.18%)

$100

22 days ago
(09-May-2025)

18/20 (90%)

$24.18 (43.32%)

378

Hold

2 months 13 days ago
(18-Mar-2025)

3/3 (100%)

$10.44 (17.24%)

499

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GMED (Globus Medical) average time for price targets to be met?

On average it took 294.7 days on average for the stock forecasts to be realized with a an average price target met ratio 92.98

Which analyst has the current highest performing score on GMED (Globus Medical) with a proven track record?

JASON WITTES

Which analyst has the most public recommendations on GMED (Globus Medical)?

Jason Wittes has 9 price targets and 8 ratings on GMED

Which analyst is the currently most bullish on GMED (Globus Medical)?

Jason Wittes with highest potential upside - $55.82

Which analyst is the currently most reserved on GMED (Globus Medical)?

Steven Lichtman with lowest potential downside - -$36.18

Globus Medical in the News

Q1 2025 Globus Medical Inc Earnings Call

Participants Brian Kearns; Investor Relations; Globus Medical Inc Daniel Scavilla; President, Chief Executive Officer, Director; Globus Medical Inc Keith Pfeil; Chief Financial Officer, Chief Operating Officer; Globus Medical Inc Matthew Miksic; Analyst; Barclays Vikramjeet Chopra; Analyst; Wells Fargo Richard Newitter; Analyst; Truist Securities Mathew Blackman; Analyst; Stifel Shagun Singh; Analyst; RBC Caitlin Cronin; Analyst; Canaccord...

Globus Medical Inc (GMED) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...

Revenue: $598 million, down 0.8% on a constant currency basis. Non-GAAP EPS: $0.68, an increase of 9% versus prior year. Free Cash Flow: $141 million, up 493% versus prior year. US Spine Growth: 2% in Q1. Enabling Technology Sales: $22 million, a decrease of 31% versus prior year. International Spine Implant Growth: 1% on a...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?